Lawyers for SAC Capital put a jolt into the SEC when they said accused trader Mathew Martoma had no short positions on two drug stocks and did not profit from them
A sprawling government investigation into insider trading keeps leading back to Cohen's SAC Capital. An inside look at the probe and where it's heading